Patients
Bio-Path is conducting multiple clinical studies in adults with hematologic malignancies or solid tumors.
Additionally, Metoclopramide should not be taken by anyone with a history of seizures, bleeding ulcers, Parkinson’s, high blood pressure, asthma, and liver or kidney failure. Order Motilium no Prescription Over The Counter The FDA said there were reports of cardiac arrhythmias, cardiac arrest and sudden death in patients receiving an IV form of the drug, and that that form was no longer being marketed. Read the disclaimer This document Copyright © 1993-2018 David McAuley, Pharm.D. Synthroid Patient Assistance Subacute thyroiditis 2.Abbreviated study descriptions are below. For more detailed inclusion and exclusion criteria and a list of sites where the study is enrolling, please visit the appropriate clinicatrials.gov listing.
Acute Myeloid Leukemia (AML)
Study stage: Phase 2
Recruiting status: open
Candidate: prexigebersen (BP1001)
Other medications: Venetoclax, Decitabine
Patient characteristics:
untreated AML patients; refractory/relapsed AML patients; venetoclax resistant or intolerant AML patients
Age: 18yr and older
Advanced or Recurrent Solid Tumors
Study stage: Phase 1/1b
Recruiting status: not yet recruiting
Candidate: BP-1001-A
Other medications: paclitaxel
Patient characteristics:
patients with advanced or recurrent solid tumors with a focus on ovarian or endometrial tumors in Phase 1b
Age: 18yr and older
Advanced Lymphoid Malignancies
Study stage: Phase 1
Recruiting status: open
Candidate: prexigebersen-A (BP1001-A)
Other medications: none
Patient characteristics:
patients with relapsed or refractory lymphoid malignancies such as (but not limited to) mantle cell lymphoma, PTCL, follicular lymphoma, Hodgkin lymphoma and DLBCL
Age: 18yr and older
Refractory or Relapsed AML
Study stage: Phase 1/1b
Recruiting status: not yet recruiting
Candidate: BP1002
Other medications: decitabine
Patient characteristics:
patients with refractory or relapsed AML
Age: 18yr and older
